Novo Nordisk Aktie
60,40
EUR
-3,38
EUR
-5,30
%
60,37
EUR
-3,29
EUR
-5,17
%
Werbung
Novo Nordisk Aktie Analyse
08.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
07.06.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.06.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
03.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
27.05.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
24.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
20.05.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.05.22 | Novo Nordisk Overweight | Barclays Capital | |
Werbung
|
|||
11.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
05.05.22 | Novo Nordisk Outperform | Bernstein Research | |
05.05.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
03.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
29.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
29.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
29.04.22 | Novo Nordisk Outperform | Bernstein Research | |
29.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
28.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
27.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
21.04.22 | Novo Nordisk Outperform | Bernstein Research | |
19.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
14.04.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.04.22 | Novo Nordisk Neutral | Credit Suisse Group | |
29.03.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
22.03.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
16.03.22 | Novo Nordisk Buy | Deutsche Bank AG | |
04.03.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.03.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
04.03.22 | Novo Nordisk Hold | Deutsche Bank AG | |
28.02.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
15.02.22 | Novo Nordisk Overweight | Barclays Capital | |
08.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
07.02.22 | Novo Nordisk Hold | Deutsche Bank AG | |
03.02.22 | Novo Nordisk Neutral | UBS AG | |
03.02.22 | Novo Nordisk Outperform | Bernstein Research | |
03.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
03.02.22 | Novo Nordisk Hold | Deutsche Bank AG | |
03.02.22 | Novo Nordisk Neutral | Credit Suisse Group | |
02.02.22 | Novo Nordisk Outperform | Bernstein Research | |
02.02.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.02.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
02.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
26.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
26.01.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
25.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
24.01.22 | Novo Nordisk Outperform | Bernstein Research | |
06.01.22 | Novo Nordisk Hold | Deutsche Bank AG |
Werbung
Werbung